A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance-Reference-Cited by-同舟云学术

A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance

Published:2016-02 Issue: Volume:70 Page:111-122
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Alexander Paul E.,Gionfriddo Michael R.,Li Shelly-Anne,Bero Lisa,Stoltzfus Rebecca J.,Neumann Ignacio,Brito Juan P.,Djulbegovic Benjamin,Montori Victor M.,Norris Susan L.,Schünemann Holger J.,Thabane Lehana,Guyatt Gordon H.

Publisher

Elsevier BV

Subject

Epidemiology

Reference37 articles.

1. Improving the use of research evidence in guideline development: 1. guidelines for guidelines;Schünemann;Health Res Policy Syst,2006

2. Use of evidence in WHO recommendations;Oxman;Lancet,2007

3. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables;Guyatt;J Clin Epidemiol,2011

4. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations;Guyatt;BMJ,2008

5. Guidelines for WHO Guidelines (WHO) 2003. Version 10, 2003. EIP/GPE/EQC/2003.1.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How strong is the evidence supporting the WHO guidelines on physical activity, sedentary behaviour and sleep in early childhood?;European Journal of Clinical Investigation;2024-07-31

2. Uncovering gaps in GRADE reporting of Eastern Association for the Surgery of Trauma (EAST) guidelines;Journal of Clinical Epidemiology;2024-05

3. “Going into the black box”: a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations;Frontiers in Public Health;2024-03-22

4. Traditional Chinese medicine for insomnia: Recommendation mapping of the global clinical guidelines;Journal of Ethnopharmacology;2024-03

5. The Influence of Professionals’ Personal Views and Values in the Development of Guidelines for Rare Diseases: an Example from Phenylketonuria;2024